Exact Mass: 656.4781

Exact Mass Matches: 656.4781

Found 88 metabolites which its exact mass value is equals to given mass value 656.4781, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PA(P-16:0/18:2(9Z,12Z))

[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]phosphonic acid

C37H69O7P (656.4781)


2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. 2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is irreversibly produced from 2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl))-sn-glycero-3-phosphoethanolamine via the enzyme phospholipase D (EC: 3.1.4.4). Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. 2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.

   
   

Undecapropylene glycol

Undecapropylene glycol

C33H68O12 (656.4711)


   

Inostamycin C

Inostamycin C

C37H68O9 (656.4863)


   

PA(P-16:0e/18:2(9Z,12Z))

2-(9Z,12Z-Octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate

C37H69O7P (656.4781)


   

PA(O-16:0/18:3(9Z,12Z,15Z))

1-hexadecyl-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate

C37H69O7P (656.4781)


   

PA(O-16:0/18:3(6Z,9Z,12Z))

1-hexadecyl-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate

C37H69O7P (656.4781)


   

PA(P-16:0/18:2(9Z,12Z))

1-(1Z-hexadecenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

C37H69O7P (656.4781)


   

PA O-34:3

1-(1Z-hexadecenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

C37H69O7P (656.4781)


   

Annosquatin-I

Annosquatin-I

C37H68O9 (656.4863)


   

Mgdg O-8:0_20:2

Mgdg O-8:0_20:2

C37H68O9 (656.4863)


   

Mgdg O-22:2_6:0

Mgdg O-22:2_6:0

C37H68O9 (656.4863)


   

Mgdg O-26:2_2:0

Mgdg O-26:2_2:0

C37H68O9 (656.4863)


   

Mgdg O-19:2_9:0

Mgdg O-19:2_9:0

C37H68O9 (656.4863)


   

Mgdg O-9:0_19:2

Mgdg O-9:0_19:2

C37H68O9 (656.4863)


   

Mgdg O-20:2_8:0

Mgdg O-20:2_8:0

C37H68O9 (656.4863)


   

Mgdg O-21:2_7:0

Mgdg O-21:2_7:0

C37H68O9 (656.4863)


   

Mgdg O-24:2_4:0

Mgdg O-24:2_4:0

C37H68O9 (656.4863)


   

Mgdg O-14:1_14:1

Mgdg O-14:1_14:1

C37H68O9 (656.4863)


   

Mgdg O-13:1_15:1

Mgdg O-13:1_15:1

C37H68O9 (656.4863)


   

Mgdg O-16:2_12:0

Mgdg O-16:2_12:0

C37H68O9 (656.4863)


   

Mgdg O-18:2_10:0

Mgdg O-18:2_10:0

C37H68O9 (656.4863)


   

Mgdg O-10:0_18:2

Mgdg O-10:0_18:2

C37H68O9 (656.4863)


   

Mgdg O-11:0_17:2

Mgdg O-11:0_17:2

C37H68O9 (656.4863)


   

Mgdg O-15:1_13:1

Mgdg O-15:1_13:1

C37H68O9 (656.4863)


   

Mgdg O-12:0_16:2

Mgdg O-12:0_16:2

C37H68O9 (656.4863)


   

Mgdg O-17:2_11:0

Mgdg O-17:2_11:0

C37H68O9 (656.4863)


   

Fahfa 44:11

Fahfa 44:11

C44H64O4 (656.4804)


   

BisMePA(32:3)

BisMePA(16:2(1)_16:1)

C37H69O7P (656.4781)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 18:4/O-26:7

FAHFA 18:4/O-26:7

C44H64O4 (656.4804)


   

FAHFA 18:5/O-26:6

FAHFA 18:5/O-26:6

C44H64O4 (656.4804)


   

FAHFA 18:6/O-26:5

FAHFA 18:6/O-26:5

C44H64O4 (656.4804)


   

FAHFA 19:4/O-25:7

FAHFA 19:4/O-25:7

C44H64O4 (656.4804)


   

FAHFA 19:5/O-25:6

FAHFA 19:5/O-25:6

C44H64O4 (656.4804)


   

FAHFA 19:6/O-25:5

FAHFA 19:6/O-25:5

C44H64O4 (656.4804)


   

FAHFA 20:4/O-24:7

FAHFA 20:4/O-24:7

C44H64O4 (656.4804)


   

FAHFA 20:5/O-24:6

FAHFA 20:5/O-24:6

C44H64O4 (656.4804)


   

FAHFA 20:6/O-24:5

FAHFA 20:6/O-24:5

C44H64O4 (656.4804)


   

FAHFA 21:4/O-23:7

FAHFA 21:4/O-23:7

C44H64O4 (656.4804)


   

FAHFA 21:5/O-23:6

FAHFA 21:5/O-23:6

C44H64O4 (656.4804)


   

FAHFA 21:6/O-23:5

FAHFA 21:6/O-23:5

C44H64O4 (656.4804)


   

FAHFA 21:7/O-23:4

FAHFA 21:7/O-23:4

C44H64O4 (656.4804)


   

FAHFA 22:4/O-22:7

FAHFA 22:4/O-22:7

C44H64O4 (656.4804)


   

FAHFA 22:5/O-22:6

FAHFA 22:5/O-22:6

C44H64O4 (656.4804)


   

FAHFA 22:6/O-22:5

FAHFA 22:6/O-22:5

C44H64O4 (656.4804)


   

FAHFA 22:7/O-22:4

FAHFA 22:7/O-22:4

C44H64O4 (656.4804)


   

FAHFA 23:4/O-21:7

FAHFA 23:4/O-21:7

C44H64O4 (656.4804)


   

FAHFA 23:5/O-21:6

FAHFA 23:5/O-21:6

C44H64O4 (656.4804)


   

FAHFA 23:6/O-21:5

FAHFA 23:6/O-21:5

C44H64O4 (656.4804)


   

FAHFA 23:7/O-21:4

FAHFA 23:7/O-21:4

C44H64O4 (656.4804)


   

FAHFA 24:5/O-20:6

FAHFA 24:5/O-20:6

C44H64O4 (656.4804)


   

FAHFA 24:6/O-20:5

FAHFA 24:6/O-20:5

C44H64O4 (656.4804)


   

FAHFA 24:7/O-20:4

FAHFA 24:7/O-20:4

C44H64O4 (656.4804)


   

FAHFA 25:5/O-19:6

FAHFA 25:5/O-19:6

C44H64O4 (656.4804)


   

FAHFA 25:6/O-19:5

FAHFA 25:6/O-19:5

C44H64O4 (656.4804)


   

FAHFA 25:7/O-19:4

FAHFA 25:7/O-19:4

C44H64O4 (656.4804)


   

FAHFA 26:5/O-18:6

FAHFA 26:5/O-18:6

C44H64O4 (656.4804)


   

FAHFA 26:6/O-18:5

FAHFA 26:6/O-18:5

C44H64O4 (656.4804)


   

FAHFA 26:7/O-18:4

FAHFA 26:7/O-18:4

C44H64O4 (656.4804)


   

FAHFA 44:11;O

FAHFA 44:11;O

C44H64O4 (656.4804)


   

MGDG O-28:2

MGDG O-28:2

C37H68O9 (656.4863)


   
   

PA O-14:0/20:3

PA O-14:0/20:3

C37H69O7P (656.4781)


   

PA O-14:1/20:2

PA O-14:1/20:2

C37H69O7P (656.4781)


   

PA O-16:0/18:3

PA O-16:0/18:3

C37H69O7P (656.4781)


   

PA O-16:1/18:2

PA O-16:1/18:2

C37H69O7P (656.4781)


   

PA O-16:2/18:1

PA O-16:2/18:1

C37H69O7P (656.4781)


   

PA O-18:2/16:1

PA O-18:2/16:1

C37H69O7P (656.4781)


   

PA O-20:2/14:1

PA O-20:2/14:1

C37H69O7P (656.4781)


   

PA P-14:0/20:2

PA P-14:0/20:2

C37H69O7P (656.4781)


   

PA P-14:0/20:2 or PA O-14:1/20:2

PA P-14:0/20:2 or PA O-14:1/20:2

C37H69O7P (656.4781)


   

PA P-16:0/18:2

PA P-16:0/18:2

C37H69O7P (656.4781)


   

PA P-16:0/18:2 or PA O-16:1/18:2

PA P-16:0/18:2 or PA O-16:1/18:2

C37H69O7P (656.4781)


   

PA P-16:1/18:1

PA P-16:1/18:1

C37H69O7P (656.4781)


   

PA P-16:1/18:1 or PA O-16:2/18:1

PA P-16:1/18:1 or PA O-16:2/18:1

C37H69O7P (656.4781)


   

PA P-18:1/16:1

PA P-18:1/16:1

C37H69O7P (656.4781)


   

PA P-18:1/16:1 or PA O-18:2/16:1

PA P-18:1/16:1 or PA O-18:2/16:1

C37H69O7P (656.4781)


   

PA P-20:1/14:1

PA P-20:1/14:1

C37H69O7P (656.4781)


   

PA P-20:1/14:1 or PA O-20:2/14:1

PA P-20:1/14:1 or PA O-20:2/14:1

C37H69O7P (656.4781)


   
   

PA P-34:2 or PA O-34:3

PA P-34:2 or PA O-34:3

C37H69O7P (656.4781)


   
   
   

MGDG(28:2)

MGDG(10:1(1)_18:1)

C37H68O9 (656.4863)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

3-[(13s)-2,13-dihydroxy-13-[(2s,5r)-5-[(1r,4s,5r)-1,4,5-trihydroxypentadecyl]oxolan-2-yl]tridecyl]-5-hydroxy-5-methylfuran-2-one

3-[(13s)-2,13-dihydroxy-13-[(2s,5r)-5-[(1r,4s,5r)-1,4,5-trihydroxypentadecyl]oxolan-2-yl]tridecyl]-5-hydroxy-5-methylfuran-2-one

C37H68O9 (656.4863)


   

3-[5'-ethyl-2'-hydroxy-5'-(1-hydroxybutyl)-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-7-(3-ethyl-4,6-dihydroxy-5-methyl-6-propyloxan-2-yl)-6-hydroxy-5-methyloctan-4-one

3-[5'-ethyl-2'-hydroxy-5'-(1-hydroxybutyl)-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-7-(3-ethyl-4,6-dihydroxy-5-methyl-6-propyloxan-2-yl)-6-hydroxy-5-methyloctan-4-one

C37H68O9 (656.4863)


   

(5s)-3-[(2s,13r)-2,13-dihydroxy-13-[(2s,5r)-5-[(1r,4r,5r)-1,4,5-trihydroxypentadecyl]oxolan-2-yl]tridecyl]-5-hydroxy-5-methylfuran-2-one

(5s)-3-[(2s,13r)-2,13-dihydroxy-13-[(2s,5r)-5-[(1r,4r,5r)-1,4,5-trihydroxypentadecyl]oxolan-2-yl]tridecyl]-5-hydroxy-5-methylfuran-2-one

C37H68O9 (656.4863)


   

(3r,5s,6s,7s)-3-[(2s,2'r,3'r,4s,5s,5'r)-5'-ethyl-2'-hydroxy-5'-[(1s)-1-hydroxybutyl]-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-7-[(2r,3s,4r,5s,6s)-3-ethyl-4,6-dihydroxy-5-methyl-6-propyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

(3r,5s,6s,7s)-3-[(2s,2'r,3'r,4s,5s,5'r)-5'-ethyl-2'-hydroxy-5'-[(1s)-1-hydroxybutyl]-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-7-[(2r,3s,4r,5s,6s)-3-ethyl-4,6-dihydroxy-5-methyl-6-propyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

C37H68O9 (656.4863)